PMI Appoints Christos Harpantidis as Senior Vice President

PMI by 2FIRSTS.ai
Mar.27.2024
PMI Appoints Christos Harpantidis as Senior Vice President
Christos Harpantidis appointed as PMI Senior VP of Global External Affairs effective May 1, 2024, succeeding Grégoire Verdeaux.

According to a report from Business Wire on March 26th, Philip Morris International (PMI) announced that Christos Harpantidis has been appointed as the company's Senior Vice President for global external affairs, effective May 1, 2024. Harpantidis will report directly to CEO Jacek Olczak in his new role.

 

Since joining PMI in 2003, Harpantidis has held several positions, including formulating the commercialization strategy for smoke-free products in Lausanne, Switzerland, and serving as the Chairman and General Manager of Papastratos Company in Greece. Most recently, he has been serving as Vice President of PMI for the Southeast European region. Throughout his career at PMI, Harpantidis has been dedicated to expanding the company's smoke-free consumer base, increasing the brand portfolio, and promoting regulations that align with PMI's smoke-free goals.

 

This personnel change is to replace Grégoire Verdeaux, who is leaving at the end of the month to pursue other career opportunities. During his tenure, Verdeaux expanded the company's global tobacco harm reduction strategy and worked with the team to establish influential policy positions, earning regulatory support in line with the smoke-free vision.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

The U.S. Department of Justice and FDA seized 2.1 million e-cigarettes and 12 distributors and retailers were sued
The U.S. Department of Justice and FDA seized 2.1 million e-cigarettes and 12 distributors and retailers were sued
Recently, the U.S. Department of Justice and the FDA announced a joint crackdown on illegal e-cigarettes, seizing over 2.1 million unauthorized e-cigarette products from five distributors and six retailers in seven states. The companies involved had previously received warnings from the FDA but continued to sell products without market approval. This operation was jointly carried out by multiple government departments, and civil injunction lawsuits have been filed against 12 related companies an
Sep.30 by 2FIRSTS.ai
Poland Plans Total Prohibition of Single-Use Vapes to Protect Youth
Poland Plans Total Prohibition of Single-Use Vapes to Protect Youth
Poland’s Ministry of Health has proposed legislation to ban all disposable e-cigarettes — both with and without nicotine — under a new amendment to tobacco product laws. The government aims to protect youth from nicotine addiction while reducing public health and environmental harm. Medical professionals largely support the move but call for balanced harm-reduction strategies.
Nov.25 by 2FIRSTS.ai
Chonburi Police Raid Major E-Cigarette and Vape Liquid Warehouse Worth Over US$920,000
Chonburi Police Raid Major E-Cigarette and Vape Liquid Warehouse Worth Over US$920,000
Thailand Chonburi provincial police, in coordination with multiple agencies, raided a large-scale warehouse in downtown Chonburi used for producing and distributing e-cigarettes and vape liquids. Two Chinese nationals were arrested, and more than 40 categories of contraband—including vapes, e-liquids, and production equipment—were seized, with an estimated total value exceeding US$920,000 (about 30 million Thai baht).
Nov.17 by 2FIRSTS.ai
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesia’s National Police Criminal Investigation Department (Bareskrim Polri) will continue to take enforcement action against users and distributors of etomidate-laced vape liquids, even though the substance is not yet classified as a narcotic. Brigadier General Eko Hadi Santoso, Director of Narcotics Crimes, said etomidate is an anaesthetic drug regulated under Health Law No. 17 of 2023, but has not been listed as a narcotic or psychotropic substance.
Oct.23 by 2FIRSTS.ai
Thai Cabinet Approves NHRC Proposal to Tighten E-Cigarette Regulation
Thai Cabinet Approves NHRC Proposal to Tighten E-Cigarette Regulation
Thailand’s Cabinet approved a National Human Rights Commission proposal to tighten e-cigarette regulation. The Health Ministry was instructed to raise public awareness on vaping risks and amend the 2017 Tobacco Control Act to cover all tobacco products, including vapes and new forms, while enforcing WHO FCTC Article 5.3 to prevent industry interference.
Oct.28 by 2FIRSTS.ai
ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.
Nov.24 by 2FIRSTS.ai